Riskpilot← Back to searchSign inGet full accessOPUS FUNGUS ApS
APSActiveCVR 31468833Dr Neergaards Vej 3Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2008— employees
Revenue 2024
DKK 0
EBITDA margin
—
-222% vs 2023
Equity ratio
96.1%
Financial strength
Net profit 2024
DKK 11M
+199% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -81K | -222% |
| Net profit | DKK 11M | +199% |
| Total assets | DKK 29,6M | +48% |
| Equity | DKK 28,5M | +45% |
| Employees | — | — |
Legal name
OPUS FUNGUS ApS
CVR number
31468833
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
20. maj 2008
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at være holdingselskab for anpartshavernes ejerandele af selskaber i handels-, produktions-og investeringsvirksomheder.
Address
Dr Neergaards Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -18 | -9 | -6 | -10 | -20 | -13 | -15 | -13 | -11 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -18 | -9 | -6 | -10 | -20 | -13 | -15 | -13 | -11 | -20 | -31 | -25 | -81 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -18 | -9 | -6 | -10 | -20 | -13 | -15 | -13 | -11 | -20 | -31 | -25 | -81 |
| Net financials | 969 | 505 | 1.723 | 1.847 | 1.140 | 979 | 884 | 1.365 | -637 | 1.395 | 15.118 | -11.073 | 10.065 |
| Profit before tax | 951 | 496 | 1.717 | 1.837 | 1.120 | 966 | 869 | 1.352 | -648 | 1.375 | 15.087 | -11.099 | 9.984 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 3 | 88 | 30 | -1.004 |
| Net profit | 951 | 496 | 1.717 | 1.837 | 1.120 | 966 | 869 | 1.352 | -648 | 1.371 | 14.999 | -11.129 | 10.989 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.694 | 4.758 | 6.230 | 6.970 | 7.927 | 8.473 | 8.741 | 9.094 | 14.594 | 17.404 | 32.011 | 19.962 | 29.615 |
| Equity | 4.685 | 4.749 | 6.217 | 6.954 | 7.910 | 8.456 | 8.725 | 9.078 | 14.588 | 16.879 | 31.128 | 19.699 | 28.469 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 9 | 14 | 16 | 16 | 17 | 16 | 16 | 6 | 525 | 883 | 263 | 1.146 |
| Total debt | 9 | 9 | 14 | 16 | 16 | 17 | 16 | 16 | 6 | 525 | 883 | 263 | 1.146 |
EBITDA margin
-8090600.0%
This company
15.8%
Market median
-51206429% vs market
20122024
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
20122024
Return on equity
38.6%
This company
18.4%
Market median
+110% vs market
20122024
Net profit margin
1098879100.0%
This company
8.1%
Market median
+13566408542% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OPUS FUNGUS ApS 
BactiQuant A/SBoard members of OPUS FUNGUS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|